» Articles » PMID: 29367243

Immunogenicity in Rabbits of HIV-1 SOSIP Trimers from Clades A, B, and C, Given Individually, Sequentially, or in Combination

Overview
Journal J Virol
Date 2018 Jan 26
PMID 29367243
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

Recombinant soluble HIV-1 envelope glycoprotein (Env) SOSIP trimers are a design platform for inducing broadly neutralizing antibodies (bNAbs) by vaccination. To date, these and alternative designs of native-like trimers, given singly or in pairs, have not induced bNAbs in test animals such as rabbits or macaques. Here, we have evaluated whether trivalent and tetravalent combinations of SOSIP trimers from clades A, B, and C, delivered simultaneously or sequentially, induce better neutralizing antibody responses in rabbits than when given alone. None of the tested formulations led to the induction of bNAbs. We found that BG505 clade A trimers dominated the autologous NAb responses induced by combinations, which probably relates to the presence of immunodominant glycan holes on the BG505 trimer. Furthermore, autologous NAb responses to all individual trimers were reduced when they were delivered in combinations compared with when delivered alone, suggesting that immunogen interference had occurred. Finally, in a sequential regimen, a heterologous clade C trimer cross-boosted NAb responses that were primed by earlier immunizations with clade A and B trimers. Taken together, these findings should allow us to improve the design of immunization regimens based on native-like HIV-1 Env trimers. A successful HIV-1 vaccine most probably requires a trimeric envelope glycoprotein (Env) component, as Env is the only viral protein on the surface of the virus and therefore the only target for neutralizing antibodies. Native-like Env trimers can induce strain-specific neutralizing antibodies but not yet broadly neutralizing antibodies. To try to broaden the antibody response, we immunized rabbits with soluble native-like Env trimers from three different clades using monovalent, multivalent, and sequential regimens. We found that the neutralizing antibody response against each immunogen was reduced when the immunogens were delivered in combination or sequentially compared to the monovalent regimen. In contrast, when the Env trimers from different clades were delivered sequentially, the neutralizing antibody response could be cross-boosted. Although the combination of native-like Env trimers from different clades did not induce broadly neutralizing antibodies, the results provide clues on how to use native-like trimers in vaccination experiments.

Citing Articles

Progress and Challenges in HIV-1 Vaccine Research: A Comprehensive Overview.

Boomgarden A, Upadhyay C Vaccines (Basel). 2025; 13(2).

PMID: 40006695 PMC: 11860913. DOI: 10.3390/vaccines13020148.


The Design and Immunogenicity of an HIV-1 Clade C Pediatric Envelope Glycoprotein Stabilized by Multiple Platforms.

Kumar S, Moral-Sanchez I, Singh S, Newby M, Allen J, Bijl T Vaccines (Basel). 2025; 13(2).

PMID: 40006657 PMC: 11860714. DOI: 10.3390/vaccines13020110.


Inducible cell lines producing replication-defective human immunodeficiency virus particles containing envelope glycoproteins stabilized in a pretriggered conformation.

Ding H, Nguyen H, Li W, Deshpande A, Zhang S, Jiang F J Virol. 2024; 98(12):e0172024.

PMID: 39508605 PMC: 11650979. DOI: 10.1128/jvi.01720-24.


Mosaic and mixed HIV-1 glycoprotein nanoparticles elicit antibody responses to broadly neutralizing epitopes.

Brinkkemper M, Kerster G, Brouwer P, Tran A, Torres J, Ettema R PLoS Pathog. 2024; 20(10):e1012558.

PMID: 39361585 PMC: 11449375. DOI: 10.1371/journal.ppat.1012558.


Design and immunogenicity of an HIV-1 clade C pediatric envelope glycoprotein stabilized by multiple platforms.

Kumar S, Moral-Sanchez I, Singh S, Newby M, Allen J, Bijl T bioRxiv. 2024; .

PMID: 39345501 PMC: 11429718. DOI: 10.1101/2024.09.14.613016.


References
1.
Sanders R, Derking R, Cupo A, Julien J, Yasmeen A, de Val N . A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies. PLoS Pathog. 2013; 9(9):e1003618. PMC: 3777863. DOI: 10.1371/journal.ppat.1003618. View

2.
Bhiman J, Anthony C, Doria-Rose N, Karimanzira O, Schramm C, Khoza T . Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies. Nat Med. 2015; 21(11):1332-6. PMC: 4637988. DOI: 10.1038/nm.3963. View

3.
Bricault C, Kovacs J, Nkolola J, Yusim K, Giorgi E, Shields J . A multivalent clade C HIV-1 Env trimer cocktail elicits a higher magnitude of neutralizing antibodies than any individual component. J Virol. 2014; 89(5):2507-19. PMC: 4325749. DOI: 10.1128/JVI.03331-14. View

4.
Torrents de la Pena A, Julien J, de Taeye S, Garces F, Guttman M, Ozorowski G . Improving the Immunogenicity of Native-like HIV-1 Envelope Trimers by Hyperstabilization. Cell Rep. 2017; 20(8):1805-1817. PMC: 5590011. DOI: 10.1016/j.celrep.2017.07.077. View

5.
Moore P, Gray E, Wibmer C, Bhiman J, Nonyane M, Sheward D . Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape. Nat Med. 2012; 18(11):1688-92. PMC: 3494733. DOI: 10.1038/nm.2985. View